| Attenuated peptide YY release in obese subjects is associated with reduced satiety CW Le Roux, RL Batterham, SJB Aylwin, M Patterson, CM Borg, ... Endocrinology 147 (1), 3-8, 2006 | 664 | 2006 |
| The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control DJ Pournaras, C Glicksman, RP Vincent, S Kuganolipava, ... Endocrinology 153 (8), 3613-3619, 2012 | 434 | 2012 |
| Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects CW Le Roux, M Patterson, RP Vincent, C Hunt, MA Ghatei, SR Bloom The Journal of Clinical Endocrinology & Metabolism 90 (2), 1068-1071, 2005 | 355 | 2005 |
| Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes DJ Pournaras, A Osborne, SC Hawkins, RP Vincent, D Mahon, P Ewings, ... Annals of surgery 252 (6), 966-971, 2010 | 301 | 2010 |
| Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding S Scholtz, AD Miras, N Chhina, CG Prechtl, ML Sleeth, NM Daud, ... Gut 63 (6), 891-902, 2014 | 300 | 2014 |
| Eating slowly increases the postprandial response of the anorexigenic gut hormones, peptide YY and glucagon-like peptide-1 A Kokkinos, CW le Roux, K Alexiadou, N Tentolouris, RP Vincent, ... The Journal of Clinical Endocrinology & Metabolism 95 (1), 333-337, 2010 | 284 | 2010 |
| Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation CW le Roux, C Borg, K Wallis, RP Vincent, M Bueter, R Goodlad, ... Annals of surgery 252 (1), 50-56, 2010 | 214 | 2010 |
| Endoscopic duodenal–jejunal bypass liner rapidly improves type 2 diabetes C de Jonge, SS Rensen, FJ Verdam, RP Vincent, SR Bloom, ... Obesity surgery 23, 1354-1360, 2013 | 175 | 2013 |
| Changes in gut hormones after bariatric surgery RP Vincent, CW Le Roux Clinical endocrinology 69 (2), 173-179, 2008 | 149 | 2008 |
| Systematic review: bile acids and intestinal inflammation‐luminal aggressors or regulators of mucosal defence? P Pavlidis, N Powell, RP Vincent, D Ehrlich, I Bjarnason, B Hayee Alimentary pharmacology & therapeutics 42 (7), 802-817, 2015 | 129 | 2015 |
| The effect of bariatric surgery on intestinal absorption and transit time KA Carswell, RP Vincent, AP Belgaumkar, RA Sherwood, SA Amiel, ... Obesity surgery 24, 796-805, 2014 | 129 | 2014 |
| Increased secondary/primary bile acid ratio in chronic heart failure CCK Mayerhofer, T Ueland, K Broch, RP Vincent, GF Cross, CP Dahl, ... Journal of Cardiac Failure 23 (9), 666-671, 2017 | 110 | 2017 |
| A 13-steroid serum panel based on LC-MS/MS: use in detection of adrenocortical carcinoma DR Taylor, L Ghataore, L Couchman, RP Vincent, B Whitelaw, D Lewis, ... Clinical chemistry 63 (12), 1836-1846, 2017 | 101 | 2017 |
| Temporal changes in bile acid levels and 12α-hydroxylation after Roux-en-Y gastric bypass surgery in type 2 diabetes R Dutia, M Embrey, S O'brien, RA Haeusler, KK Agénor, P Homel, ... International journal of obesity 39 (5), 806-813, 2015 | 91 | 2015 |
| Changes in bile acid profile after laparoscopic sleeve gastrectomy are associated with improvements in metabolic profile and fatty liver disease AP Belgaumkar, RP Vincent, KA Carswell, RD Hughes, ... Obesity surgery 26, 1195-1202, 2016 | 87 | 2016 |
| Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery M Werling, RP Vincent, GF Cross, HU Marschall, L Fändriks, H Lönroth, ... Scandinavian journal of gastroenterology 48 (11), 1257-1264, 2013 | 81 | 2013 |
| Higher circulating bile acid concentrations in obese patients with type 2 diabetes RP Vincent, S Omar, S Ghozlan, DR Taylor, G Cross, RA Sherwood, ... Annals of clinical biochemistry 50 (4), 360-364, 2013 | 81 | 2013 |
| Mechanisms of disease: the role of gastrointestinal hormones in appetite and obesity RP Vincent, H Ashrafian, CW Le Roux Nature clinical practice Gastroenterology & hepatology 5 (5), 268-277, 2008 | 81 | 2008 |
| The satiety hormone peptide YY as a regulator of appetite RP Vincent, CW Le Roux Journal of clinical pathology 61 (5), 548-552, 2008 | 73 | 2008 |
| Supraphysiological doses of intravenous PYY3-36 cause nausea, but no additional reduction in food intake CW le Roux, CM Borg, KG Murphy, RP Vincent, MA Ghatei, SR Bloom Annals of clinical biochemistry 45 (1), 93-95, 2008 | 73 | 2008 |
